ICU Medical, Inc.
ICUI
$140.19
-$1.40-0.99%
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Revenue | 5.44% | 4.04% | 0.46% | -2.10% | -0.92% |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | 5.44% | 4.04% | 0.46% | -2.10% | -0.92% |
Cost of Revenue | 2.50% | 4.31% | 0.52% | -3.82% | -3.98% |
Gross Profit | 11.48% | 3.48% | 0.33% | 1.68% | 6.04% |
SG&A Expenses | 5.29% | 6.64% | 3.43% | 0.67% | -0.27% |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 3.32% | 4.88% | 1.27% | -2.54% | -3.17% |
Operating Income | 103.62% | -25.77% | -31.46% | 38.85% | 1,440.70% |
Income Before Tax | 15.69% | -75.87% | -24.48% | -39.29% | 31.56% |
Income Tax Expenses | 206.23% | 100.28% | 9.68% | -57.10% | -21.24% |
Earnings from Continuing Operations | -296.86% | -295.83% | -45.98% | -28.86% | 60.08% |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -296.86% | -295.83% | -45.98% | -28.86% | 60.08% |
EBIT | 103.62% | -25.77% | -31.46% | 38.85% | 1,440.70% |
EBITDA | 14.57% | -7.13% | -7.11% | 0.11% | 19.44% |
EPS Basic | -292.15% | -290.68% | -44.33% | -27.63% | 60.56% |
Normalized Basic EPS | 76.47% | -75.64% | -122.87% | -32.83% | 24.06% |
EPS Diluted | -292.64% | -290.49% | -44.37% | -27.56% | 60.52% |
Normalized Diluted EPS | 76.42% | -76.30% | -122.45% | -32.59% | 24.24% |
Average Basic Shares Outstanding | 1.23% | 1.02% | 0.94% | 0.80% | 0.97% |
Average Diluted Shares Outstanding | 0.98% | 0.78% | 1.19% | 1.04% | 1.21% |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |